Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice

Streamson C. Chua, Jr.,1 Shun Mei Liu,1 Qiong Li,1 Aijun Sun,2 Walter F. DeNino,2 Steven B. Heymsfield,2 and X. Edward Guo3

Departments of 1Pediatrics and 3Biomedical Engineering, Columbia University, New York 10032; and 2New York Obesity Research Center, St. Luke's-Roosevelt Hospital, New York, New York 10025

Submitted 31 July 2003 ; accepted in final form 28 October 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We have generated mice that are homozygous for a leptin receptor transgene that is expressed exclusively in neurons (NSE-LEPR-B). We had previously shown that this transgene in the hemizygous state is effective in ameliorating almost all aspects of leptin receptor deficiency. Now, we show that the transgene, in the homozygous state, almost fully corrects the excess adiposity of LEPR-deficient (db/db) mice. Body composition analyses indicate that the transgene is able to restrain the massive increase in adiposity observed in LEPR-deficient mice. Examination of hypothalamic agouti gene-related peptide and proopiomelanocortin mRNA shows normalization of these leptin-regulated transcripts. Interestingly, despite normalization of circulating leptin concentrations by the transgene in the fed state, transgenic db3J/db mice did not show fasting-induced reductions of circulating leptin. Increased adiposity of the transgenic db/db mice at 4 wk of age, immediately postweaning, suggests that the transgene is less effective in correcting the preferential fat deposition caused by LEPR deficiency. We noted that the morphology of brown adipose tissue is nearly normal, concordant with the cold tolerance conferred by the transgene. Aspects of the diabetes phenotype are also corrected: glucose and insulin concentrations are nearly normal, and islet hyperplasia is greatly diminished. The transgene also corrects the infertility of db/db females and confers the ability to lactate sufficiently to nurse normal-sized litters. Finally, the slightly increased adiposity and mild insulin resistance of transgenic db/db dams were not a contributory factor to the increased fat content of transgenic db/db male progeny.

monogenic model of obesity; hypothalamus


THE ADIPOCYTE-DERIVED HORMONE LEPTIN acts on multiple organs, and its effects are readily examined in animal models of leptin (ob/ob) and leptin receptor (db/db) deficiency (18). On initial observation of these animal models, one is immediately struck by the massive obesity that is caused by hyperphagia, decreased thermogenesis, and preferential deposition of triglycerides in white fat. These phenotypes are mediated by leptin's actions (4) on hypothalamic neurons bearing the signal transduction and transactivator (STAT)-signaling competent isoform of leptin receptor, LEPR-B (7). All of the phenotypes relevant to obesity and diabetes are probably mediated by these LEPR-B-bearing hypothalamic neurons (6, 17). However, direct effects of leptin are also manifest in the T cells of the immune system (20, 21), platelets (15, 23), and vascular endothelium (3, 30). Signal transduction pathways independent of STATs may mediate some of these actions.

We have previously reported the effects of a transgene, NSE-LEPR-B, which expresses solely in the mouse central nervous system due to the specificity conferred by the neuron-specific enolase (ENO2) promoter (17). This transgene in the hemizygous state ameliorates, but does not fully normalize, all of the phenotypes of diabetes mice related to energy balance, namely hyperphagia, defective nonshivering thermogenesis, and obesity, along with correcting the infertility of males. However, the hemizygous transgenic db/db mice still exhibited increased adiposity, insulin resistance, and female infertility.

Leptin treatment of ob/ob females restores fertility, but the females fail to lactate (6). A similar phenotype of restoration of fertility with failure of lactation is observed in ob/ob Y4-receptor double-mutant females (28). Because ob/ob females without neuropeptide Y (NPY) are partially fertile and successfully raise their pups (10), it is quite likely that overexpression of NPY is affecting prolactin release, perhaps via effects on hypothalamic dopaminergic neurons. Hemizygous transgenic db/db females are infertile, and we were unable to determine their ability to lactate.

As the partial correction of the phenotypes by the NSELEPR-B transgene was probably due to mosaic expression of the transgene within the brain, we reasoned that it would be possible to improve the normalization of the obesity/diabetes phenotypes of db/db mice by increased expression of the transgene in the homozygous state. There are instances in which a tyrosinase transgene in the homozygous state conferred increased and more uniform pigmentation over the hemizygous condition in albino, tyrosinase-deficient mice (22, 31).

In this report, we describe the effects of the NSE-LEPR-B transgene in the homozygous condition on the body composition of db/db mice, along with its effects on female fertility. Because homozygous transgenic db/db females are fertile, we are also able to assess their ability to lactate and suckle their pups. Because our model is based on correcting the LEPR-deficient phenotypes on a transgene expressed in the brain, we should be able to evaluate the neurally mediated actions of the leptin-leptin receptor system on peripheral organ systems.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals. Growth data were obtained on a cohort of NSE-LEPR-B mice (12-20 mice/group). Other data have group sizes specified for each data set. Animals were fed a standard laboratory diet (Picolab Mouse Diet 20: 55% carbohydrate, 20% protein, 9% fat; PMI Nutrition International) and water ad libitum. All animals were housed under barrier conditions at 22°C with a 14:10-h light-dark cycle. Pathogen testing was done on a quarterly basis, and all serologies were negative throughout the study. Genotyping was done as previously described (17). For simplicity, we refer to the Lepr db allele as db and the Lepr db3J allele as db3J. We have performed parallel analyses between transgenic db/db and transgenic db3J/db3J mice, and we have not observed difference in growth or body composition between the two genotypes (unpublished data, S. C. Chua). For the purposes of analyses, mice of these two genotypes have been grouped together. Similarly, nontransgenic db/db and db3J/db3J mice have also been grouped together when data were available. The genotypes of mice are specified in the figure legends when relevant.

Live mice were weighed on an Ohaus balance with a precision to 0.1 g. Animals were euthanized by asphyxiation with carbon dioxide. Euthanized animals were weighed using a precision balance (AC 100, Mettler), and nasoanal length measurements were taken.

Blood for leptin, glucose, and insulin concentration determinations was collected from live, awake mice via a nicked tail vein. Serum samples from fed animals were collected between 0900 and 1200, and those from fasted animals were collected between 0900 and 1200 after an overnight fast (chow removed at 1800) or after a 5-h fast with serum collected at 1400 after chow removal at 0900. All procedures were described in protocols that were approved by the Columbia University Institutional Animal Care and Use Committee. These procedures were designed to minimize distress and pain.

Production of homozygous transgenic animals. Transgenic hemizygotes were mated to produce putative transgene homozygous animals. Homozygosity was verified by test matings to wild-type animals and subsequent genotyping of the progeny. Mice that produced all transgenic progeny (>=10 pups tested) when mated to wild-type animals were considered transgenic (Tr) homozygotes. Progeny from subsequent matings between transgenic homozygotes were not tested. Colonies were maintained by matings between db3J/db3J Tg/Tg pairs or db3J/+ Tg/Tg mice mated to db3J/db3J Tg/Tg mates. Compound db/db3J heterozygotes were produced by matings between db/db Tg/Tg or db/+ Tg/Tg mice and db3J/+ Tg/Tg mates.

Tissue histology. Pancreata were fixed in Bouin's solution, whereas other tissues were fixed in buffered formalin. Tissues were embedded in paraffin, and 5-µm sections were cut. Pancreatic sections were immunostained for insulin content and counterstained with hematoxylin. Other tissues were stained with hematoxylin and eosin. Digital images were obtained on a Nikon Eclipse 400 microscope and a SPOT Insight digital camera.

Assessment of female fertility. Transgenic db/db females were mated at 6-8 wk to transgenic db/db males. The number of days from mating to the delivery of the first litter was recorded. The number of pups born and the number of pups weaned 21 days after birth were noted. Ovaries of euthanized virgin females were removed and processed for histology.

Dual-energy X-ray absorptiometry. Whole body and tibia dual-energy X-ray absorptiometry (DEXA) measurements were made on a Lunar PIXIMUS scanner (Lunar Piximus, GE Medical Systems, Waukesha, Wisconsin) functioning in the pencil beam mode. Before each series of scans, a tissue calibration scan was performed using the manufacturer's provided phantom. Live mice were anesthetized with a ketamine-xylazine mixture. Each mouse was placed on the scanner dish in a prone position with fore and hind legs outspread. Scans provided determinations of fractional body fat content, total body fat mass, and total fat-free mass.

Hormone and glucose measurements. Glucose was determined on whole blood with a Bayer glucometer with immobilized glucose oxidase. Insulin and leptin concentrations in serum were measured with ELISA kits from Alpco (insulin) and Crystal Chem (leptin), with mouse insulin and leptin as standards (15). Serum levels of hormones were quantified using commercial radioimmunoassay kits (Diagnostic Systems Laboratories).

Quantification of neuropeptide mRNA. Hypothalamic RNA was isolated and used for cDNA synthesis and amplification, as described previously (17). Agouti gene-related peptide (AGRP) and proopiomelanocortin (POMC) mRNAs were analyzed using hypoxanthine-phosphoribosyltransferase (HPRT) mRNA as an internal control for each sample. Real-time quantification was performed on an Opticon 2 (MJ Research, Waltham, MA). The data were analyzed to correct for differences in amplification efficiencies and normalized to HPRT mRNA content (25).

Statistical analysis. All values are expressed as means ± SD unless otherwise noted. Group differences were tested for significance using the Student's unpaired t-test after initial tests to show a significant effect of genotype. Data from the hypothalamic neuropeptide mRNA quantification were analyzed by a nonparametric test, the Wilcoxon rank-sum test.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Near-normal adiposity in db/db mice homozygous for the NSE-LEPR-B transgene. We have generated a line of mice, backcrossed to the C57BL/6J strain for four generations, that is homozygous for the NSE-LEPR-B transgene by standard mating procedures. We have found no evidence of deleterious effects of the homozygous condition, suggesting that the transgene does not disrupt any essential genes. The transgenic homozygous mice (db/+ and +/+) are fully fertile, and we have not observed any phenotypic differences from wild-type animals.

The growth curves of transgenic db/db and db/+ mice are presented in Fig. 1. The growth curves of transgenic db3J/db3J and transgenic db/db mice are not significantly different, and the data are pooled in Fig. 1. Between 1 and 3 mo of age, transgenic db/db mice of both sexes are heavier than transgenic db/+ mice. At 4 mo of age, the male db/+ transgenic and db/db transgenic mice have equivalent weights. At 6 mo of age, the male db/+ transgenic males are actually heavier than the db/db transgenic males, whereas the db/+ and db/db transgenic females are equivalent in weight.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Growth curves of leptin receptor-deficient (db/db) and transgenic db/db mice. Growth curves of male (A) and female (B) mice are presented. Data points for db/+ Tg and db/db Tg mice represent weights of groups of 10-18 mice of each genotype/sex combination. Points for db/db mice are means of 4-5 mice for each sex and are presented for comparison purposes. *Significantly different from db/+ Tg/Tg groups.

 

We performed body composition analysis by DEXA on mice at 1 and 6 mo of age, comparing transgenic and nontransgenic mice (Fig. 2). The db/db mice of both sexes have the highest adipose tissue mass and fractional body fat at both ages, as expected. At 1 mo of age, transgenic db/db mice of both sexes have adipose mass that is intermediate between genetically lean (db/+ and Tg db/+) and genetically obese (db/db) mice. At 6 mo of age, the transgenic db/db male mice have body compositions that are very similar to transgenic db/+ males. However, the nontransgenic db/+ mice had a lower mean fat mass than either of the transgenic male groups, suggesting that either the transgene itself has an effect or that residual CBA alleles, derived from the transgenic founder B6xCBA F2 mouse, may be contributing to increased adiposity. The adult transgenic db/db female mice still have slightly increased fat-free mass relative to db/+ and transgenic db/+ mice. There are some minor effects on fat-free mass, such as the increased fat-free mass in 1-mo-old male db/db mice, which, although significant, represent a small fraction of the total body mass. It is interesting to note that the 6-mo-old transgenic db/db males have a slightly lower fat-free mass than any of the other male genotypes. In summary, the data demonstrate that a major effect of the transgene in the homozygous state is the restraint on the massive increase in fat mass (>20 g over 5 mo) in postweaning db/db mice.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2. Fat mass and fat-free mass of transgenic db/db mice. Fat mass (A and C) and fat-free mass (B and D) of males and females at 1 and 6 mo of age, as determined by dual-energy X-ray absorptiometry (DEXA), are presented in absolute weights for the 4 genotypes. Group sizes for transgenic mice ranged from 8 to 16, whereas group sizes for nontransgenic mice were 3-7. *Statistically significant difference from db/+ group, ^difference from db/+ Tg/Tg group (db/db and db/db Tg/Tg groups only), and @difference between db/db and db/dbTg/Tg groups. #Fat-free mass of male transgenic db/db mice at 6 mo was lower than that of all other groups.

 

Leptin concentrations in transgenic db3J/db mice are not reduced by fasting. We measured leptin concentrations in fed transgenic db3J/db and transgenic db3J/+ mice at 5 mo of age (Fig. 3). Leptin concentrations in fed transgenic db3J/db mice (males and females) are not statistically different from those of fed transgenic db3J/+ mice. However, leptin concentrations of fed db3J/db3J males were greatly elevated. Fasting reduces the leptin concentrations in transgenic db3J/+ mice of both sexes but does not reduce the leptin concentrations of transgenic db3J/db mice of either sex, suggesting that the transgene does not completely restore modulation of leptin secretion.



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Leptin concentrations in transgenic db3J/db and db3J/+ mice. Leptin concentrations were measured by ELISA and presented as group means (n = 4-7/group). Mice were 5 mo of age. *Difference due to fasting (P < 0.01); #difference due to genotype (P < 0.01). Note that fasting leptin concentrations are not provided for db3J/db3J mice.

 

Correction of brown adipose tissue morphology by the transgene. A component of the obesity syndrome is defective nonshivering thermogenesis due to atrophy of brown adipose tissue (BAT). We had previously shown that the NSE-LEPR-B transgene normalizes cold tolerance in the hemizygous state. With the transgene in the homozygous condition, we observe normal BAT in 5- to 8-mo-old transgenic db3J/db3J mice (Fig. 4), whereas we were unable to observe any BAT in the interscapular area of db3J/db3J mice of the C57BL/6J strain (12 mice dissected). Histological examination shows the presence of adipocytes with the multiloculated fat droplets typical of brown adipocytes in the interscapular brown fat pad of transgenic db3J/db3J mice. The brown adipocytes have a slightly larger degree of lipid accumulation in transgenic female db3J/db3J mice than in lean mice or transgenic db3J/+ mice.



View larger version (98K):
[in this window]
[in a new window]
 
Fig. 4. Brown adipose tissue (BAT) morphology in transgenic db3J/db3J mice, showing representative fields of BAT lean (db3J/+ and Tg/Tg db3J/+) and transgenic db3J/db3J mice, 4- to 5-mo-old males and females. As discussed in the text, we were unable to dissect any discernible BAT from similarly aged db3J/db3J mice. Images were captured with a x20 objective lens.

 

Normalization of carbohydrate metabolism and pancreatic islet morphology. Major concomitant phenotypes associated with obesity of LEPR deficiency are glucose intolerance and pancreatic islet hyperplasia. We measured fed and fasting glucose (Fig. 5A) and insulin (Fig. 5B) concentrations in transgenic db3J/db mice at 5 mo of age. Fed glucose and insulin concentrations were indistinguishable between the two genotypes. In the fasting condition, glucose tended to be higher in the transgenic db3J/db mice but did not reach statistical significance. Fasting insulin concentrations tended to be higher in the transgenic db3J/db mice, but only the difference between the females reached statistical significance. Concordant with these findings, we observed near-normalization of islet size in the pancreata of transgenic db3J/db and transgenic db3J/db3J mice (Fig. 5C), although there were islets in the transgenic db3J/db3J pancreata that were larger than the largest islets observed in the pancreata of genetically lean mice.



View larger version (47K):
[in this window]
[in a new window]
 
Fig. 5. Measures of carbohydrate metabolism. Fed and fasting serum samples were measured for glucose (A) and insulin (B) concentrations. Group means are presented for 5-mo-old mice (n = 5-7/group). Significant difference due to *fasting or #genotype. C: pancreata were immunostained for insulin content. Representative sections from female mice of the noted genotypes are presented. Note the greatly expanded {beta}-cell no. of db3J/db3J islets, whereas transgenic db3J/db3J islets have normal cellularity.

 

Restoration of female fertility and lactation by the transgene. In the hemizygous state, the transgene did not correct the infertility of females. However, the transgene in the homozygous state restores fertility to transgenic db/db females. The data in Table 1 show that female transgenic db/db mice, when mated to male transgenic db/db or db/+ mice, become pregnant and deliver normal-sized litters. The ovaries of db/db females (Fig. 6) histologically have many large empty follicles with few primary or secondary follicles and no evidence of proper corpora lutea. The ovaries of transgenic db/db females show numerous primary and secondary follicles with the presence of corpora lutea. Moreover, the females suckle their pups and are successful in raising all of their progeny to weaning, even in their first litters (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Fertility restored in db/db females by the NSE-LEPR-B transgene

 


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 6. Ovarian morphology of db/db and transgenic db/db mice. Ovaries from virgin 4-mo-old females were processed with standard histological techniques, and sections were stained with hematoxylin and eosin. Note large, empty follicles and lack of corpora lutea in the section from the db/db female. The ovary of the transgenic db3J/db3J mouse has follicles of normal appearance with the presence of corpora lutea. Images were captured with a x4 objective lens.

 

Excess adiposity in trangenic db/db dams does not increase adiposity of progeny. Because of the increased adiposity and mild insulin resistance of the transgenic db/db females, we were concerned that our results might be affected by potential confounding maternal effects. We generated progeny from two types of mating pairs: 1) transgenic db3J/+ females mated to transgenic db3J/db3J males; and 2) transgenic db3J/db3J females mated to transgenic db3J/+ males. We determined the body compositions (Table 2) of transgenic db3J/db3J males at 4 wk of age that were produced by the two types of matings. We found no significant effect of maternal genotoype on fractional body fat content in the male progeny.


View this table:
[in this window]
[in a new window]
 
Table 2. Lack of maternal genotype effect on body fat content of male progeny

 

Transgene modulation of hypothalamic neuropeptide gene expression. We had previously shown that the transgene in the hemizygous condition normalized POMC mRNA and reduced but did not normalize AGRP mRNA. We analyzed the effect of the transgene in the homozygous state on AGRP and POMC mRNA by real-time RT-PCR (Table 3). As expected, db3J/db3J male mice have elevated AGRP mRNA and reduced POMC mRNA relative to db3J/+ mice. The transgene in the homozygous state reduced AGRP and increased POMC mRNA to concentrations that were indistinguishable from db3J/+ males.


View this table:
[in this window]
[in a new window]
 
Table 3. Transgene modulation of hypothalamic neuropeptide gene expression

 

Dose effects of the transgene on obesity and diabetes of db/db mice. We have compared some obesity and diabetes parameters of 5-mo-old hemizygous and homozygous transgenic db3J/db3J mice (Table 4) to be able to show directly a transgene dose effect. The body weights and body mass indexes (BMIs) of db3J/db3J Tg/Tg mice, both males and females, are not significantly elevated above those of db3J/+ mice. The db3J/db3J Tg (transgene in hemizygosity) mice have elevated weights and BMIs that are significantly different from the db3J/+ groups. There is also a similar gradation in fasting leptin concentrations due to the transgene dose, with the db3J/db3J Tg/Tg animals having lower leptin concentrations than the db3J/db3J Tg animals. The fasting glucose values for db3J/+ and transgenic mice are not statistically different, whereas the db3J/db3J animals have elevated glucose values. There are slight differences in the glucose and leptin data, because the data in Table 4 are collected after a 5-h fast, whereas the data in Fig. 5 are from an overnight fast.


View this table:
[in this window]
[in a new window]
 
Table 4. Transgene dose effects on obesity and diabetes in 5-mo-old db3J/db3J mice

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We have previously shown that the NSE-LEPR-B transgene has effects on all aspects of energy regulation relevant to leptin signaling (17). Mice hemizygous for the transgene and homozygous for Lepr mutations (db and db3J) were leaner, less insulin resistant, and had normal cold tolerance and lower corticosterone concentrations. Moreover, male db/db mice carrying the transgene were fertile, although female transgenic db/db mice remained infertile. In the current report, we describe the phenotypes of db/db mice with the transgene in the homozygous state. We reasoned that the increasing transgene dosage would increase LEPR expression and improve the normalization of the phenotypes related to LEPR deficiency. Our data support this proposition, because adiposity is normalized in adult male transgenic db/db mice compared with transgenic db/+ males and is nearly normalized in adult female transgenic db/db mice. The data show that the transgene in the homozygous state prevents the acquisition of >20 g (in the course of 5 mo) of body fat due to LEPR deficiency. Our conclusion is tempered by the slight differences in adiposity observed in db/+ and transgenic db/+ male mice. It is possible that the difference could be due to a transgene effect, with increased transgenic leptin receptor expression leading to increased body fat content. Alternatively, the differences might be due to residual CBA alleles, derived from the founder B6xCBA F2 mouse, that increase body fat content. The normalization of hypothalamic AGRP and POMC mRNA in adult transgenic db3J/db3J males is also consistent with the supposition that transgene homozygosity reduces mosaicism and increases transgene expression. Previously, the transgene in the hemizygous state normalized POMC mRNA but only reduced AGRP mRNA, without bringing AGRP mRNA to concentrations similar to those of lean mice.

The body composition data at 1 mo of age indicated that the transgene is less effective, compared with its efficacy in adult db/db mice, in normalizing body composition. Thus there may be components of the leptin-leptin receptor system that have differential effects in the preweanling mouse pup and the adult mouse. Further studies will be needed to define the contribution of leptin to the regulation of body composition of precocial organisms that undergo extremely rapid postnatal growth, such as the mouse pup.

Measures of leptin concentrations in the blood showed that the transgene effectively reduced leptin concentrations to the level of those found in transgenic db3J/+ mice. However, fasting did not reduce leptin in transgenic db3J/db mice, suggesting that there is still a defect in the regulation of leptin secretion that is not corrected by the transgene. We had previously remarked upon this in our analysis of transgenic hemizygous db3J/db3J animals, although the elevated circulating insulin concentrations confounded our ability to make firm conclusions (1, 2, 16, 27). With the present animals, we show that fasting insulin concentrations in transgenic db3J/db male mice are significantly reduced. In addition, the fasting insulin concentrations of transgenic db3J/db females were well below 1 ng/ml. Thus we can exclude elevated insulin concentrations in the fasting state as a stimulus to elevated fasting leptin concentrations in the transgenic db3J/db mice. The data are highly suggestive of an autoregulatory loop of adipocyte secretion of leptin (26, 32, 35-37). The growth curves of the db3J/db compound mutants were not different from those of the db and db3J homozygotes, with or without the transgene (unpublished data, S. C. Chua). We went to the effort of using db3J/db compound heterozygotes to measure circulating leptin concentrations to avoid potential confounding effects from elevations of a circulating leptin-binding protein (11) produced by the db3J mutant allele (19). The db allele provides LEPR isoforms that could contribute to leptin metabolism, perhaps for catabolism after binding to leptin receptors in the kidneys and the lungs (9, 29). This would avoid confounding results from potential leptin clearance issues that might be caused by the loss of non-B LEPR isoforms.

One component of the obesity syndrome is defective non-shivering thermogenesis (8). This defect is most likely the combined result of decreased sympathetic activation of BAT and mild central hypothyroidism that has been documented to be due to indirect and direct actions of leptin on hypothalamic TRH neurons (12, 24). We previously showed that the cold intolerance of db/db mice was corrected by the NSE-LEPR-B transgene. In this report, we show that the BAT of transgenic db3J/db3J mice has near-normal morphology, suggesting that trophic effects on BAT have been normalized by the transgene.

The glucose intolerance of LEPR-deficient mice is due to insulin resistance and strain-dependent responses to hyperglycemia (8). The NSE-LEPR transgene normalizes nearly all parameters of glucose metabolism, although female transgenic db3J/db mice did not show a fasting-induced decline in circulating insulin concentrations. There are indications of very mild insulin resistance in the transgenic db3J/db animals, although we cannot determine whether this is due to long-term effects of the excess adiposity immediately postweaning or to the absence of LEPR-B expression in some crucial neuronal types. Nevertheless, the expression of LEPR-B in neurons is sufficient to nearly normalize pancreatic islet mass. However, the current model does not allow the separation of potential trophic effects of insulin resistance/hyperglycemia on {beta}-cell mass from potential direct modulation of {beta}-cell mass from the hypothalamus.

Another aspect of leptin receptor biology relates to fertility and lactation. We note that LEP-null females treated with leptin become fertile and have normal-sized litters (5, 6). However, these leptin-treated females are unable to lactate. Similarly, LEP-null Y4-null females are fertile but fail to lactate (28). Interestingly, LEP-null, NPY-null females are fertile and successfully raise litters (10). In our transgenic db/db females, reproduction has been restored, and the ability to lactate has also been restored. These observations suggest that there may be a critical period for the action of leptin on mammary gland development that remains to be explored. As neither overexpression of NPY (14, 33) nor melanocortin-4 receptor deficiency (13) prevents mammary gland development sufficiently to affect lactation, the mechanism and neural pathways involved in leptin's regulation of the mammary gland remain to be determined.

There have been studies indicating that the db/+ genotype has an effect on body composition via a maternal effect. Female db/+ mice of the C57BLKS/J strain become glucose intolerant during pregnancy, and their progeny are macrosomic (34). We were concerned that the slightly increased adiposity of transgenic db/db dams might affect the body compositions of their progeny, potentially confounding the effects of maternal environment and the genotype of the progeny. Our data suggest that neither the increased adiposity nor the mild insulin resistance of transgenic db/db females affects the fractional body fat content of their progeny. Thus the increased adiposity of the transgenic db/db mice at 4 wk is probably due to deficient LEPR signaling during development.

The NSE-LEPR transgene has limitations in terms of addresssing the components of the neural network that mediate leptin's effects on ingestion, body composition, energy expenditure, and fertility. The transgene is unable to direct expression to neurons that are defined by their neurotransmitter content, as might be obtained by a transgene that is driven by the promoters of the Pomc or the Npy genes. However, the current model would be interesting to use to dissect the central and peripheral actions of leptin on immune cells and the skeletal system. Because the transgene effectively reduces insulin resistance and glucocorticoid concentrations, it effectively simplifies the model and removes confounding metabolic conditions that may mask the direct actions of leptin on peripheral tissues. The current model does not address questions that arise from examination of the phenotype of the transgenic db/db mice: 1) Which neurons contribute to the insulin resistance of db/db mice? 2) Which neurons are responsible for the elevated glucocorticoids of db/db mice? 3) What is the contribution of the development of insulin resistance and elevated glucocorticoids to the obesity/diabetes syndrome? 4) What are the mechanisms that cause the early-onset adiposity of preweaning db/db pups?

In summary, we have described the effects of a leptin receptor B isoform neuron-specific transgene on the phenotype of db/db mice. The transgene in the homozygous state causes near normalization of adiposity in adult db/db animals. The transgene appears to be less effective in reducing the adiposity during the preweaning phases of development. Furthermore, we have data to suggest that the maternal environment is not a factor in the increased adiposity of young transgenic db/db mice. The transgene corrects glucose intolerance and the {beta}-cell hyperplasia accompanying the insulin resistance of LEPR deficiency. Finally, the fertility of female db/db mice is restored by the transgene, along with the ability to lactate.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was funded by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-42618 (S. B. Heymsfield), DK-57621 (S. C. Chua), and DK-26687 (S. B. Heymsfield and S. C. Chua).


    FOOTNOTES
 

Address for reprint requests and other correspondence: S. C. Chua, Jr., Dept. of Pediatrics, Columbia Univ., Rm. 628 (Box 110), 1150 St. Nicholas Ave., New York, NY 10032 (E-mail: sc569{at}columbia.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhausl W, and Roden M. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52: 1792-1798, 2003.[Abstract/Free Full Text]
  2. Boden G, Chen X, Kolaczynski JW, and Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100: 1107-1113, 1997.[Abstract/Free Full Text]
  3. Bouloumie A, Drexler HC, Lafontan M, and Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83: 1059-1066, 1998.[Abstract/Free Full Text]
  4. Campfield LA, Smith FJ, Guisez Y, Devos R, and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.[ISI][Medline]
  5. Chehab FF. The reproductive side of leptin. Nat Med 3: 952-953, 1997.[ISI][Medline]
  6. Chehab FF, Lim ME, and Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12: 318-320, 1996.[ISI][Medline]
  7. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, and Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.[ISI][Medline]
  8. Chua SC Jr. Monogenic models of obesity. Behav Genet 27: 277-284, 1997.[CrossRef][ISI][Medline]
  9. Cumin F, Baum HP, and Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obes Relat Metab Disord 20: 1120-1126, 1996.[Medline]
  10. Erickson JC, Hollopeter G, and Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704-1707, 1996.[Abstract/Free Full Text]
  11. Gavrilova O, Barr V, Marcus-Samuels B, and Reitman M. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem 272: 30546-30551, 1997.[Abstract/Free Full Text]
  12. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C, Elmquist JK, Flier JS, and Hollenberg AN. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 107: 111-120, 2001.[Abstract/Free Full Text]
  13. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, and Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.[ISI][Medline]
  14. Kaga T, Inui A, Okita M, Asakawa A, Ueno N, Kasuga M, Fujimiya M, Nishimura N, Dobashi R, Morimoto Y, Liu IM, and Cheng JT. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes 50: 1206-1210, 2001.[Abstract/Free Full Text]
  15. Konstantinides S, Schafer K, Koschnick S, and Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108: 1533-1540, 2001.[Abstract/Free Full Text]
  16. Koopmans SJ, Frolich M, Gribnau EH, Westendorp RG, and De-Fronzo RA. Effect of hyperinsulinemia on plasma leptin concentrations and food intake in rats. Am J Physiol Endocrinol Metab 274: E998-E1001, 1998.[Abstract/Free Full Text]
  17. Kowalski TJ, Liu SM, Leibel RL, and Chua SC Jr. Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes 50: 425-435, 2001.[Abstract/Free Full Text]
  18. Leibel RL, Chua SC Jr, and Rosenbaum M. Obesity. In: The Metabolic and Molecular Bases of Inherited Diseases (8th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 2001, p. 3965-4028.
  19. Li C, Ioffe E, Fidahusein N, Connolly E, and Friedman JM. Absence of soluble leptin receptor in plasma from dbPas/dbPas and other db/db mice. J Biol Chem 273: 10078-10082, 1998.[Abstract/Free Full Text]
  20. Lord G. Role of leptin in immunology. Nutr Rev 60: S35-S38; S68-S87, 2002.[Medline]
  21. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, and Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901, 1998.[CrossRef][ISI][Medline]
  22. Mintz B and Bradl M. Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotes. Proc Natl Acad Sci USA 88: 9643-9647, 1991.[Abstract]
  23. Nakata M, Yada T, Soejima N, and Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48: 426-429, 1999.[Abstract/Free Full Text]
  24. Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjorbak C, and Flier JS. Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem 275: 36124-36133, 2000.[Abstract/Free Full Text]
  25. Ramakers C, Ruijter JM, Deprez RH, and Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66, 2003.[CrossRef][ISI][Medline]
  26. Rayner DV, Dalgliesh GD, Duncan JS, Hardie LJ, Hoggard N, and Trayhurn P. Postnatal development of the ob gene system: elevated leptin levels in suckling fa/fa rats. Am J Physiol Regul Integr Comp Physiol 273: R446-R450, 1997.[Abstract/Free Full Text]
  27. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, and Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47: 544-549, 1998.[Abstract]
  28. Sainsbury A, Schwarzer C, Couzens M, Jenkins A, Oakes SR, Ormandy CJ, and Herzog H. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 16: 1077-1088, 2002.[Abstract/Free Full Text]
  29. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, Kurnik PB, O'Connor J, Sinha M, and Caro JF. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51: 1980-1985, 1997.[ISI][Medline]
  30. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, and Flores-Riveros JR. Biological action of leptin as an angiogenic factor. Science 281: 1683-1686, 1998.[Abstract/Free Full Text]
  31. Tanaka S and Takeuchi T. Hair pigmentation in transgenic mice. Ann NY Acad Sci 642: 407-418, 1991.[Abstract]
  32. Turban S, Hainault I, Truccolo J, Andre J, Ferre P, Quignard-Boulange A, and Guerre-Millo M. Specific increase in leptin production in obese (fa/fa) rat adipose cells. Biochem J 362: 113-118, 2002.[CrossRef][ISI][Medline]
  33. Vezzani A, Michalkiewicz M, Michalkiewicz T, Moneta D, Ravizza T, Richichi C, Aliprandi M, Mule F, Pirona L, Gobbi M, Schwarzer C, and Sperk G. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110: 237-243, 2002.[CrossRef][ISI][Medline]
  34. Yamashita H, Shao J, Ishizuka T, Klepcyk PJ, Muhlenkamp P, Qiao L, Hoggard N, and Friedman JE. Leptin administration prevents spontaneous gestational diabetes in heterozygous Lepr(db/+) mice: effects on placental leptin and fetal growth. Endocrinology 142: 2888-2897, 2001.[Abstract/Free Full Text]
  35. Zhang Y, Guo KY, Diaz PA, Heo M, and Leibel RL. Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol 282: R226-R234, 2002.[Abstract/Free Full Text]
  36. Zhang Y, Hufnagel C, Eiden S, Guo KY, Diaz PA, Leibel R, and Schmidt I. Mechanisms for LEPR-mediated regulation of leptin expression in brown and white adipocytes in rat pups. Physiol Genomics 4: 189-199, 2001.[Abstract/Free Full Text]
  37. Zhang Y, Olbort M, Schwarzer K, Nuesslein-Hildesheim B, Nicolson M, Murphy E, Kowalski TJ, Schmidt I, and Leibel RL. The leptin receptor mediates apparent autocrine regulation of leptin gene expression. Biochem Biophys Res Commun 240: 492-495, 1997.[CrossRef][ISI][Medline]